Expandable Mesh-Balloon Spacer for Transcatheter Tricuspid Repair

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Heart valve regurgitation, particularly tricuspid valve regurgitation, is often treated with open-heart surgery, which is invasive and risky, while catheter-based techniques lack effective solutions for proper valve repair.

Innovation Solution

A transcatheter device with a main shaft, distal tail, and spacer body is designed for minimally invasive treatment, featuring a guidewire lumen, nitinol wire lumen, and injection tube lumen, along with a spacer body that can expand to provide a coaptation surface for tricuspid valve leaflets, anchored by a distal tail in the pulmonary artery and intravascular anchor in the vena cava.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If open-heart surgery with cardiopulmonary bypass is used to treat tricuspid valve regurgitation, then effective valve repair can be achieved, but the procedure becomes highly invasive and risky

Engineering Contradiction:
Improvevalve repair effectivenessVSAvoidsurgical invasiveness and risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The device is divided into multiple functional segments: a distal tail for anchoring in the pulmonary artery, a spacer body for creating the coaptation surface, and a proximal portion with an intravascular anchor for stabilization in the vena cava. This segmentation allows the complex valve repair function to be achieved through a minimally invasive catheter-based approach rather than requiring full open-heart surgery with cardiopulmonary bypass.

Inventive Principle:
Principle #1Segmentation

2Object-affected harmful factors

If catheter-based techniques are used for valve repair, then surgical invasiveness is reduced, but effective solutions for proper valve repair are lacking

Engineering Contradiction:
Improvesurgical invasivenessVSAvoidvalve repair effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The spacer body acts as an intermediary structure that creates a coaptation surface between the tricuspid valve leaflets. This intermediary element enables proper valve closure and eliminates regurgitation without requiring direct manipulation of the valve apparatus, thus achieving effective repair through a minimally invasive catheter-based approach.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The device is delivered through a catheter in a compressed state and then expanded at the target site within the heart. This preliminary compression allows the entire repair mechanism to be delivered through a small vascular access point, and the expansion at the destination creates the coaptation surface in the optimal position for valve repair.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If a spacer body is expanded to provide a coaptation surface, then tricuspid regurgitation is effectively treated, but device complexity increases

Engineering Contradiction:
Improvetricuspid regurgitation treatment effectivenessVSAvoiddevice structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The spacer body transitions from a compressed delivery state to an expanded functional state at the target site. This dynamic transformation allows the device to maintain a simple, low-profile configuration during delivery through the catheter, then expand to provide the necessary coaptation surface for effective tricuspid regurgitation treatment.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The spacer body is nested within the delivery catheter in a compressed state, allowing the entire device to be delivered through a minimally invasive approach. Once positioned, the spacer body expands from its nested configuration to provide the coaptation surface, effectively treating the regurgitation without requiring complex external support structures.

Inventive Principle:
Principle #7Nested doll (Nesting)

Data Source

PatentEP4603059A1Transcatheter device
Publication Date: 2025.08.20 TAU MEDICAL INC
  • EP4603059A1 patent drawingFigure 1A
  • EP4603059A1 patent drawingFigure 1B
  • EP4603059A1 patent drawingFigure 1C~1D(c)

AI summary

A transcatheter device includes: a main shaft including a proximal portion, an intermediate portion, and a distal portion, and having a first lumen for insertion of a guidewire, a second lumen for insertion of a nitinol wire, and a third lumen for insertion of an injection tube formed therein; a distal tail comprising a distal portion of the main shaft; a spacer body mounted on the intermediate portion positioned between the distal portion and the proximal portion of the main shaft, in which the proximal portion of the main shaft includes a proximal segment and an intravascular anchor connected to the proximal segment, and wherein the spacer body comprises: a mesh structured body configured contractible or expandable and to be expanded to have a predetermined configuration in the absence of an external force from an environment; and a balloon configured to cover the mesh structured body to maintain an enclosed state, and to be controlled in size depending on an amount of a saline solution injected into an internal space thereof.